Study Group: Lung Disease Challenges in Myositis: Diagnosis, Treatment & Screening

Coordinator(s)

• 

  Paul Dellaripa, MD

  brigham
• 

  Jiri Vencovsky, MD, PhD

  Institute of Rheumatology

This session will discuss important aspects of diagnostics, assessment and treatment of patients with interstitial lung diseases (ILD) in myositis and other rheumatic diseases.

Learning Objectives:

• Discuss the value of different imaging modalities, particularly HRCT, in the diagnostics of various forms of ILD in myositis
• Discuss the existing data, ongoing clinical trials, and real world experience on the use of antifibrotics for the treatment of ILD in patients with systemic autoimmune rheumatic diseases
• Discuss screening practices for ILD in different subtypes of inflammatory myopathies and review treatment of myositis-associated ILD